Finanzwire Finanzwire
Basculer en Français
11164 Companies
246578 Keywords
174512 Articles
133164 Press releases
Headlines Articles Press releases Americord Remove
  1. Home
  2. Companies
  3. Americord
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/23/2024 at 16:30, 2 years 7 months ago

    Americord makes breakthrough in treating Motor Neuron Disease with cord blood stem cells

    Americord Stem Cells Cord Blood Motor Neuron Disease Treatment
  • PRESS RELEASE

    published on 02/23/2024 at 16:30, 2 years 7 months ago

    Americord Releases Cord Blood Stem Cells for Treatment of Motor Neuron Disease

    Americord releases cord blood stem cells for the treatment of motor neuron disease in India, highlighting the therapeutic potential of stem cells in healthcare
    Healthcare Americord Motor Neuron Disease Treatment Cord Blood Stem Cells
    Logo of Americord
  • PRESS RELEASE

    published on 12/06/2023 at 15:00, 2 years 10 months ago

    Americord Elevates Standards With Strategic Lab Relocation to Somerset, New Jersey

    Americord, a leader in the biobanking industry, has relocated its laboratory from New York City to a state-of-the-art facility in Somerset, New Jersey, marking a milestone in advancing research, product quality, and growth opportunities
    Americord Biobanking Laboratory Relocation Research Somerset New Jersey
    Logo of Americord
Accesswire
  • Published on 10/13/2026 at 14:10, 10 minutes ago

    NioCorp Places 100% of Its Planned Critical Minerals Production Under Commercial Sales Agreements

  • Published on 10/13/2026 at 14:00, 20 minutes ago

    Orogen Royalties Enters into Agreement to Sell the Slaughterhouse Copper-Gold Project to Seabridge Gold

  • Published on 10/13/2026 at 14:00, 20 minutes ago

    Fermi Signs Credit Support Agreement with AMD and Announces Partnership

  • Published on 10/13/2026 at 13:30, 50 minutes ago

    British Columbia Court Declares The Helix Resources Joint Venture on The Gold Basin Property is Set Aside and is Unenforceable

  • Published on 10/13/2026 at 13:30, 50 minutes ago

    Digi Power X Announces $200 Million Debt Financing Commitment to Support Completion of Alabama AI Data Center and Provides Expansion Update

View all ACCESSWIRE
EQS Group
  • Published on 10/13/2026 at 14:05, 15 minutes ago

    IDC Raises 2029 Forecast for OCP-Recognized Infrastructure Spending by 2.7x to $800 Billion

  • Published on 10/13/2026 at 14:00, 20 minutes ago

    Eckert & Ziegler and TerThera Sign Supply Agreement to Bring Next-Generation GMP Terbium-161 Radiopharmaceutical Therapies to Brazilian Patient

  • Published on 10/13/2026 at 13:20, 1 hour ago

    Shanghai and Hamburg's 40 years marked

  • Published on 10/13/2026 at 13:16, 1 hour 3 minutes ago

    IVU wins order for BVG depot management

  • Published on 10/13/2026 at 13:14, 1 hour 6 minutes ago

    EQS-Adhoc: ElringKlinger raises 2026 full-year revenue guidance

View all EQS
Les Echos
  • Published on 10/13/2026 at 09:04, 5 hours 15 minutes ago

    Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards

  • Published on 10/12/2026 at 17:59, 20 hours 20 minutes ago

    Reporting on share buyback transactions carried out between October 7 and October 9, 2026

  • Published on 10/12/2026 at 17:45, 20 hours 35 minutes ago

    Weekly share buyback

  • Published on 10/12/2026 at 17:45, 20 hours 35 minutes ago

    Declaration of transactions on own shares from October 5, 2026 to October 11, 2026

  • Published on 10/12/2026 at 15:47, 22 hours 32 minutes ago

    Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy